Rang & Dale's Pharmacology , 9th Edition

Description

World-renowned coverage of today’s pharmacology at your fingertips

Reviews

"This book is well suited for a graduate-level pharmacology course for MS or PhD students or MD/PhD students."

-Carol L Beck, PharmD, PhD (Thomas Jefferson University) Doody's Review Score: 90-4 Stars!

Key Features

• Keeps you up-to-date with new information in this fast-changing field, including significantly revised coverage of CNS drugs, cognitive enhancers, anti-infectives, biologicals/biopharmaceuticals, lifestyle drugs, and more.
• Includes access to unique features online, including more than 100 brand new chapter-specific multiple-choice questions and 6 new cases for immediate self-assessment.
• Features a color-coded layout for faster navigation and cross-referencing.
• Clarifies complex concepts with Key Points boxes, Clinical Uses boxes and full-color illustrations throughout.
• Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Companion Products

• Rang & Dale's Pharmacology, 9th Edition
• Rang & Dale's Pharmacology, 9th Edition
• LIC -Rang & Dale's Pharmacology, 9th Edition
• Rang & Dale's Pharmacology Elsevier E-Book on VitalSource, 9th Edition : Rang & Dale's Pharmacology Elsevier E-Book on VitalSource

Readership

Pharmacology, medicine, clinical pharmacology, pharmacy

Table of Contents

• View Table of Contents

Author Information

By Humphrey P. Rang, MB BS MA DPhil Hon FBPharmacolS FMedSci FRS , Emeritus Professor of Pharmacology, University College London, London, UK; James M. Ritter, DPhil FRCP FBPharmacolS FMedSci, Emeritus Professor of Clinical Pharmacology, King’s College London, and Medical Research Director, Quintiles, London, UK; Rod J. Flower, PhD DSc FBPharmacolS FMedSci FRS, Professor, Biochemical Pharmacology, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London, UK; Graeme Henderson, BSc PhD FBPharmacolS FSB, Professor of Pharmacology, University of Bristol, Bristol, UK; Yoon Kong Loke, MB, BS, MRCP, MD, Senior Lecturer in Clinical Pharmacology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK and David MacEwan, PhD, FRSB, FBPhS, SFHEA, Professor of Molecular Pharmacology/Toxicology & Head of Department, Department of Molecular and Clinical Pharmacology, University of Liverpool Liverpool, United Kingdom